The natural world is a rich source of inspiration for developing sophisticated computational systems, and the opposite is also true, with bioinformatics approaches providing keen insight into ...

BrainWhisperer is Tether’s Brain-to-text project. Tether is earmarking resources to build technologies that push the borders of intracranial electrocortical decoding. The latest result is a variable ...

Abstract: Polarization-adjusted convolutional (PAC) codes are a recently proposed novel coding scheme that introduces a rate-one convolutional pre-transform before the polar transform, offering ...

The origin of many diseases begins at the cellular level and involves multiple molecular interactions. However, previous methods have struggled to accurately observe changes in individual cells.

When you find yourself going shopping and you're looking for a deal, did you know that there's a secret language that could unlock even more savings at your favorite discount stores? That includes ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. You’re listening to our weekly science news roundup. First up, a new AI model could help ...

Generalized pustular psoriasis (GPP) is the rarest form of psoriasis, a chronic autoimmune skin condition. Unlike other forms, GPP can be severe or even life-threatening. The disease causes flares of ...

Here’s a cheat sheet for decoding this year’s A.I.-driven tech lingo, from RAG to superintelligence. By Brian X. Chen Brian X. Chen is The Times’s lead consumer technology writer and the author of ...

The room we are in is locked. It is windowless and lit from above by a fluorescent bulb. In the hallway outside—two stories beneath the city of London—attendants in dark suits patrol silently, giving ...

The FDA has approved the CD19+ B-cell targeted therapy inebilizumab-cdon (Uplizna, Amgen) for the treatment of adults with generalized myasthenia gravis (gMG) who test positive for anti-acetylcholine ...

Please provide your email address to receive an email when new articles are posted on . FDA approves inebilizumab-cdon for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine ...

Inebilizumab-cdon is approved for anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody–positive generalized myasthenia gravis, based on MINT trial results. The MINT trial ...